Efficacy of interventions with live combined <i>Bacillus subtilis</i> and <i>Enterococcus faecium</i> enteric-coated capsules in metabolic associated fatty liver disease patients: a meta-analysis of randomized controlled trials.

Front Pharmacol · 2025 · PMC12148908 · PMID 40495889

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

If the P value of Begg’s test was less than 0.05, it indicated that there might be significant publication bias.

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Efficacy of interventions with live combined &lt;i&gt;Bacillus subtilis&lt;/i&gt; and &lt;i&gt;Enterococcus faecium&lt;/i&gt; enteric-coated capsules in metabolic associated fatty liver disease patients: a meta-analysis of randomized controlled trials.

The sentences

Efficacy of interventions with live combined <i>Bacillus subtilis</i> and <i>Enterococcus faecium</i> enteric-coated capsules in metabolic associated fatty liver disease patients: a meta-analysis of randomized controlled trials.